NG101m Adjuvant Therapy in Glioblastoma Patients

Clinical trial NCT04373785 · NOT_YET_RECRUITING

Trial details

NCT number: NCT04373785
Sponsor: NeuGATE Theranostics
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Glioblastoma Multiforme

Start date: 2027-01-01
Primary completion: 2030-07-30
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.